Colgate-Palmolive Company (CL) Shares Sold by Farmers National Bank
Farmers National Bank lessened its position in Colgate-Palmolive Company (NYSE:CL) by 1.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 61,879 shares of the company’s stock after selling 846 shares during the quarter. Colgate-Palmolive accounts for approximately 2.7% of Farmers National Bank’s portfolio, making the stock its 8th largest holding. Farmers National Bank’s holdings in Colgate-Palmolive were worth $4,588,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Financial Advisors Network Inc. increased its stake in Colgate-Palmolive by 4.0% in the first quarter. Financial Advisors Network Inc. now owns 4,234 shares of the company’s stock valued at $302,000 after acquiring an additional 164 shares during the last quarter. Adalta Capital Management LLC purchased a new stake in Colgate-Palmolive during the first quarter valued at about $634,000. Summit Global Investments boosted its position in Colgate-Palmolive by 26.6% during the first quarter. Summit Global Investments now owns 43,818 shares of the company’s stock valued at $3,207,000 after buying an additional 9,201 shares during the period. OLD Mutual Customised Solutions Proprietary Ltd. boosted its position in Colgate-Palmolive by 12.9% during the first quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 28,790 shares of the company’s stock valued at $2,107,000 after buying an additional 3,290 shares during the period. Finally, Notis McConarty Edward boosted its position in Colgate-Palmolive by 4.9% during the first quarter. Notis McConarty Edward now owns 14,550 shares of the company’s stock valued at $1,065,000 after buying an additional 675 shares during the period. 73.16% of the stock is currently owned by institutional investors and hedge funds.
Several brokerages have commented on CL. Jefferies Group LLC restated a “hold” rating and issued a $76.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, May 17th. Vetr cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 target price on the stock. in a report on Wednesday, May 17th. Royal Bank Of Canada reiterated a “hold” rating and set a $74.00 price target on shares of Colgate-Palmolive in a research note on Thursday, May 25th. Bank of America Corporation lifted their price target on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a research note on Wednesday, May 31st. Finally, BidaskClub cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Saturday, June 24th. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $75.82.
Shares of Colgate-Palmolive Company (NYSE CL) traded down 0.01% during trading on Wednesday, reaching $71.94. 568,353 shares of the company traded hands. The firm has a 50 day moving average of $71.62 and a 200 day moving average of $73.32. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27. The stock has a market capitalization of $63.37 billion, a PE ratio of 26.73 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.72. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The firm had revenue of $3.83 billion during the quarter, compared to analysts’ expectations of $3.89 billion. During the same period last year, the business earned $0.70 earnings per share. Colgate-Palmolive’s revenue was down .5% compared to the same quarter last year. On average, equities analysts predict that Colgate-Palmolive Company will post $2.89 EPS for the current year.
In other Colgate-Palmolive news, insider Patricia Verduin sold 3,833 shares of Colgate-Palmolive stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $75.67, for a total transaction of $290,043.11. Following the completion of the sale, the insider now directly owns 53,022 shares in the company, valued at $4,012,174.74. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Justin Skala sold 74,374 shares of Colgate-Palmolive stock in a transaction dated Thursday, July 27th. The shares were sold at an average price of $72.51, for a total transaction of $5,392,858.74. Following the sale, the chief operating officer now owns 97,177 shares of the company’s stock, valued at $7,046,304.27. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 221,802 shares of company stock valued at $15,983,976. 1.02% of the stock is owned by company insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.